More specifically, single nucleotide polymorphisms (SNPs) related to the Cntn2 gene could predict responsiveness to intravenous immunoglobulin (IVIG) treatment in patients with CIDP [94], but its presence was not correlated with clinical characteristics of the disease [95]. The gene discussed is CNTN2; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.